Dec. 5 at 3:27 PM
$AGEN **Vinay Prasad, MD, MPH**, is the current Director (head) of the FDA's Center for Biologics Evaluation and Research (CBER) as of December 5, 2025. He was originally appointed in May 2025 by FDA Commissioner Marty Makary to succeed Peter Marks, who resigned amid disagreements over vaccine policy under HHS Secretary Robert F. Kennedy Jr. Prasad, a hematologist-oncologist and former professor at the University of California, San Francisco, briefly stepped down in late July 2025 to avoid distracting the agency, but he was reinstated just over a week later at the FDA's request. Recent reports from late November and early December 2025 confirm his ongoing leadership role, including his additional designation as the agency's chief medical and scientific officer.
